Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA
Camilla Olaisen, Lisa Marie Røst, Animesh Sharma, Caroline Krogh Søgaard, Tiffany Khong, Sigrid Berg, Mi Jang, Aina Nedal, Andrew Spencer, Per Bruheim, Marit Otterlei · 2024
Read Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA by Camilla Olaisen, Lisa Marie Røst, Animesh Sharma, Caroline Krogh Søgaard, Tiffany Khong, Sigrid Berg, Mi Jang, Aina Nedal, Andrew Spencer, Per Bruheim, Marit Otterlei (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11640687.txt.
Description
Camilla Olaisen and ten co-authors test an experimental peptide drug, ATX-101, on multiple myeloma cells, a cancer of blood plasma cells. The drug targets PCNA, a protein that helps cells copy DNA and cope with stress. The study came out in twenty twenty-four.
Cells under more strain in their protein clean up and folding systems proved most weak to the drug. The team used lab grown lines and patient derived lines, and read gene, signal protein, and small molecule shifts all at once. All lines changed in many ways after care, though strength of response varied. Lines from the same patient at later disease stages tended to be more weak to the drug.
Catalog record
| CREATOR | Camilla Olaisen, Lisa Marie Røst, Animesh Sharma, Caroline Krogh Søgaard, Tiffany Khong, Sigrid Berg, Mi Jang, Aina Nedal, Andrew Spencer, Per Bruheim, Marit Otterlei |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |